<DOC>
	<DOCNO>NCT01063023</DOCNO>
	<brief_summary>To assess effect BMS-650032 Pharmacokinetics ( PK ) ethinyl estradiol ( EE ) norelgestromin ( NGMN ) healthy female subject</brief_summary>
	<brief_title>Drug Interaction Oral Contraceptive Pill ( OCP )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Healthy Females , 1840 year , BMI 18 32kg/mÂ² . Must use acceptable method contraception avoid pregnancy throughout study 8 week last dose study drug Abnormal pap smear within 1 year prior day 1 Any significant chronic uncontrolled medical illness</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>